Your browser doesn't support javascript.
loading
Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial.
Robbins, Jonathan A; Tait, Dereck; Huang, Qinlei; Dubey, Sheri; Crumley, Tami; Cote, Josee; Luk, Julie; Sachs, Jeffrey R; Rutkowski, Kathryn; Park, Harriet; Schwab, Robert; Howitt, William Joseph; Rondon, Juan Carlos; Hernandez-Illas, Martha; O'Reilly, Terry; Smith, William; Simon, Jakub; Hardalo, Cathy; Zhao, Xuemei; Wnek, Richard; Cope, Alethea; Lai, Eseng; Annunziato, Paula; Guris, Dalya; Stoch, S Aubrey.
Afiliação
  • Robbins JA; Merck & Co., Inc., Rahway, New Jersey, USA. Electronic address: jonathan.robbins@merck.com.
  • Tait D; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA.
  • Huang Q; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Dubey S; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Crumley T; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Cote J; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Luk J; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Sachs JR; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Rutkowski K; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA.
  • Park H; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA.
  • Schwab R; Celerion, Lincoln, Nebraska, USA.
  • Howitt WJ; Bio-Kinetic Clinical Applications (QPS), Missouri, USA.
  • Rondon JC; Clinical Pharmacology of Miami, Florida, USA.
  • Hernandez-Illas M; QPS Miami Research Associates, Florida, USA.
  • O'Reilly T; Celerion, Lincoln, Nebraska, USA.
  • Smith W; Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, USA.
  • Simon J; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Hardalo C; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Zhao X; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Wnek R; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Cope A; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA.
  • Lai E; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Annunziato P; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Guris D; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Stoch SA; Merck & Co., Inc., Rahway, New Jersey, USA.
EBioMedicine ; 82: 104138, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35809371
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article País de publicação: Holanda